Toronto-listed stocks were slightly higher Wednesday mid-session, with mixed sector performances keeping indexes on an even keel. Gains primarily in commercial services, tech services and health ...
Indeed, in a study this year, Bankrate estimated that Americans are in possession of $244 in unused gift cards per person, on average. And that can add up big time: Bankrate puts the total value of ...
Home Depot Inc.'s third-quarter results this week gave a glimpse into the looming issue of tariffs for major U.S. retailers. During the conference call to discuss the results, Home Depot (HD) ...
Spirit Airlines Inc.'s stock cratered 55% Wednesday, on track for its biggest-ever one-day decline, after the company warned that its equity would be wiped out as part of a restructuring deal that ...
The Bureau of Labor Statistics reported Wednesday that the CPI rose 2.6% in October from year-ago levels (an increase from ...
James Hardie Industries Up Nearly 9%, on Pace for Largest Percent Increase in Over a Year — Data Talk James Hardie Industries PLC Sponsored ADR (JHX) is currently at $34.62, up $2.83 or 8.89% --Would ...
--Up 146.42% year-to-date; on pace for best year on record (Based on available data back to April 3, 2018) --Up 166.48% from 52 weeks ago (Nov. 15, 2023), when it closed at $173.76 ...
If that is what your trust says, your son cannot continue to live in the house permanently unless your other children agree. Essentially, the house becomes the property of all your children, and they ...
Telefonica said the World Bank's arbitration arm sided in its favor in a long-running dispute with Colombia, ordering the Latin American country to pay $379.8 million in compensation.
Suncor Energy's shares advanced after the big Canadian oil producer bumped up its dividend in the wake of hitting its debt target and a rise in cash flows in the latest quarter. In early trading ...
Kicking off my retirement from Morningstar with a tribute to the miracle of US equities. We sell different types of products and services to both investment professionals and individual investors.
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...